Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men
Tóm tắt
We evaluated insulin sensitivity and insulin secretion across the entire range of fasting (FPG) and 2-h plasma glucose (PG), and we investigated the differences in insulin sensitivity and insulin release in different glucose tolerance categories.
A total of 6,414 Finnish men (aged 57 ± 7 years, BMI 27.0 ± 3.9 kg/m2) from our ongoing population-based METSIM (Metabolic Syndrome in Men) study were included. Of these subjects, 2,168 had normal glucose tolerance, 2,859 isolated impaired fasting glucose (IFG), 217 isolated impaired glucose tolerance (IGT), 701 a combination of IFG and IGT, and 469 newly diagnosed type 2 diabetes.
The Matsuda index of insulin sensitivity decreased substantially within the normal range of FPG (−17%) and 2-h PG (−37%) and was approximately −65 and −53% in the diabetic range of FPG and 2-h PG, respectively, compared with the reference range (FPG and 2-h PG <5.0 mmol/l). Early-phase insulin release declined by only approximately −5% within the normal range of FPG and 2-h PG but decreased significantly in the diabetic range of FPG (by 32–70%) and 2-h PG (by 33–51%). Changes in insulin sensitivity and insulin secretion in relation to hyperglycemia were independent of obesity. The predominant feature of isolated IGT was impaired peripheral insulin sensitivity. Isolated IFG was characterized by impaired early and total insulin release.
Peripheral insulin sensitivity was already decreased substantially at low PG levels within the normoglycemic range, whereas impairment in insulin secretion was observed mainly in the diabetic range of FPG and 2-h PG. Obesity did not affect changes in insulin sensitivity or insulin secretion in relation to hyperglycemia.
Từ khóa
Tài liệu tham khảo
Unwin, 2002, Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention, Diabet Med, 19, 708, 10.1046/j.1464-5491.2002.00835.x
Genuth, 2003, Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care, 26, 3160, 10.2337/diacare.26.11.3160
Dunstan, 2002, The rising prevalence of diabetes mellitus and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study, Diabetes Care, 25, 829, 10.2337/diacare.25.5.829
Carnevale Schianca, 2003, The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance, Diabetes Care, 26, 1333, 10.2337/diacare.26.5.1333
Vaccaro, 2005, Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition, Diabetes Care, 28, 1786, 10.2337/diacare.28.7.1786
Qiau, 2002, Age and sex specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts, A37
Qiao, 2002, Age and sex specific prevalence of diabetes and impaired glucose regulation in 10 Asian cohorts, Diabetes Res Clin Pract, 56, 540
Haffner, 1998, The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease, Endocr Rev, 19, 583, 10.1210/edrv.19.5.0343
Faerch, 2008, Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action, Diabetologia, 51, 853, 10.1007/s00125-008-0951-x
Laakso, 2008, Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study, Diabetologia, 51, 502, 10.1007/s00125-007-0899-2
Meyer, 2006, Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans, Diabetes Care, 29, 1909, 10.2337/dc06-0438
Abdul-Ghani, 2006, Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study, Diabetes, 55, 1430, 10.2337/db05-1200
Weyer, 1999, Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance, Diabetes, 48, 2197, 10.2337/diabetes.48.11.2197
Festa, 2004, Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose, Diabetes, 53, 1549, 10.2337/diabetes.53.6.1549
Festa, 2008, Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test, Diabetes, 57, 1638, 10.2337/db07-0954
Hong, 2008, Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose, Diabet Med, 25, 73, 10.1111/j.1464-5491.2007.02329.x
van Haeften, 2002, Disturbances in beta-cell function in impaired fasting glycemia, Diabetes, 51, S265, 10.2337/diabetes.51.2007.S265
Hanefeld, 2003, Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study, Diabetes Care, 26, 868, 10.2337/diacare.26.3.868
Kim, 2001, Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus, Metabolism, 50, 590, 10.1053/meta.2001.22558
Davies, 2000, Impaired glucose tolerance and fasting hyperglycaemia have different characteristics, Diabet Med, 17, 433, 10.1046/j.1464-5491.2000.00246.x
Melchionda, 2002, WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index: insulin sensitivity and secretion in resulting subcategories of glucose tolerance, Int J Obes Relat Metab Disord, 26, 90, 10.1038/sj.ijo.0801847
Snehalatha, 2003, Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians, Diabete Metab Res Rev, 19, 329, 10.1002/dmrr.388
Tripathy, 2000, Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study, Diabetes, 49, 975, 10.2337/diabetes.49.6.975
Ferrannini, 2005, Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis, J Clin Endocrinol Metab, 90, 493, 10.1210/jc.2004-1133
Gastaldelli, 2004, Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study, Diabetologia, 47, 31, 10.1007/s00125-003-1263-9
Abdul-Ghani, 2008, The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance, Am J Physiol Endocrinol Metab, 295, E401, 10.1152/ajpendo.00674.2007
Ahrén, 2007, Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects, Diabetes Care, 30, 644, 10.2337/dc06-1759
Godsland, 2004, Loss of beta cell function as fasting glucose increases in the non-diabetic range, Diabetologia, 47, 1157, 10.1007/s00125-004-1454-z
Fuller, 1989, Potential use of bioelectrical impedance of the ‘whole body’ and of body segments for the assessment of body composition: comparison with densitometry and anthropometry, Eur J Clin Nutr, 43, 779
Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883
Stumvoll, 2001, Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times, Diabetes Care, 24, 796, 10.2337/diacare.24.4.796
Stumvoll, 2000, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity, Diabetes Care, 23, 295, 10.2337/diacare.23.3.295
Matsuda, 1999, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp, Diabetes Care, 22, 1462, 10.2337/diacare.22.9.1462
Retnakaran, 2008, Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test, Obesity (Silver Spring), 16, 1901, 10.1038/oby.2008.307
Utzschneider, 2009, Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels, Diabetes Care, 32, 335, 10.2337/dc08-1478
Abdul-Ghani, 2007, Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test, Diabetes Care, 30, 89, 10.2337/dc06-1519
Renström, 2007, Insulin resistance induced by high glucose and high insulin precedes insulin receptor substrate 1 protein depletion in human adipocytes, Metabolism, 56, 190, 10.1016/j.metabol.2006.09.012
Camastra, 2005, Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss, Diabetes, 54, 2382, 10.2337/diabetes.54.8.2382
Bock, 2007, Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis, Diabetes, 56, 1703, 10.2337/db06-1776
Frayling, 2007, Genome-wide association studies provide new insights into type 2 diabetes aetiology, Nat Rev Genet, 8, 657, 10.1038/nrg2178
Moran, 2008, Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females, Circulation, 117, 2361, 10.1161/CIRCULATIONAHA.107.704569
Ferrara, 2008, Sex differences in insulin action and body fat distribution in overweight and obese middle-aged and older men and women, Appl Physiol Nutr Metab, 33, 784, 10.1139/H08-062
Otsuki, 2005, Sex differences of age-dependent changes of insulin sensitivity in Japanese nondiabetic subjects, Diabetes Care, 28, 2590, 10.2337/diacare.28.10.2590a